Medical Devices Acquisitions in United States

Tactile Systems Technology (doing business as Tactile Medical) acquired LymphaTech Inc. for $6.8 million in upfront cash plus additional milestone-based consideration. The deal expands Tactile Medical’s lymphedema solutions portfolio by adding LymphaTech’s digital 3D body measurement and monitoring platform for lymphedema assessment and longitudinal surveillance.

Natus Sensory acquired TheraB Medical, a Michigan-based medical technology company focused on wearable phototherapy solutions for treating neonatal jaundice. The deal expands Natus Sensory’s newborn care portfolio by adding TheraB’s FDA 510(k)-cleared SnugLit swaddle-style wearable phototherapy system, supporting broader adoption of family-centered care models across hospital and other care settings.

Waters Corporation completed a previously announced combination with the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company (BD), creating a combined global life sciences and diagnostics company. The transaction was executed via a Reverse Morris Trust structure, with BD’s businesses spun off and merged into a wholly owned Waters subsidiary; post-close, Waters shareholders own 60.8% and BD shareholders own 39.2% of the combined company.

AMETEK has acquired LKC Technologies, a developer of portable ophthalmic diagnostic devices used by clinicians to test and monitor eye health. The deal expands AMETEK’s ophthalmic product portfolio and broadens its presence in eye care diagnostics, with LKC joining AMETEK’s Electronic Instruments Group.

AdaptHealth, a nationwide network of medical equipment providers, acquired Gammie HomeCare, a Hawaii-based durable medical equipment (DME) company. The transaction was one of four healthcare deals announced by Vertess Healthcare Advisors as part of its sell-side advisory closings in late 2025 and early 2026.

GCM, an outsourced manufacturer of precision components and assemblies for medical technology end markets and a portfolio company of Avista Healthcare Partners, acquired Kettmann Machining, Inc., a producer of precision‑machined plastic and metal parts for MedTech customers. The acquisition adds Kettmann’s modern 40,000-square-foot manufacturing facility in San Jose, California, expanding GCM’s capacity and high-precision manufacturing capabilities. Financial terms were not disclosed.

Symmetry Laser has completed the acquisition of ArcRev to expand its precision laser cutting capabilities and production capacity serving the medical device industry. The combination is intended to enhance support from early-stage development through high-volume manufacturing by adding complementary laser-cutting technologies and lean manufacturing expertise. Financial terms were not disclosed.

Laborie Medical Technologies Corp. closed its previously announced acquisition of the JADA System, an FDA-cleared device for rapid control and treatment of abnormal postpartum uterine bleeding (postpartum hemorrhage). The JADA System and its team will join Laborie, expanding Laborie’s obstetrics portfolio; Laborie is owned by Patricia Industries, part of Investor AB.

Aspen Surgical Products acquired Ruhof Healthcare, expanding its infection prevention, enzymatic detergent, instrument and endoscope reprocessing, and cleaning verification offerings for operating rooms, sterile processing departments, and endoscopy. The acquisition adds all Ruhof operations, brands, and product lines and is expected to strengthen Aspen Surgical’s SPD360 Performance Solutions platform; financial terms were not disclosed.

Perimeter Solutions, Inc. completed its acquisition of Medical Manufacturing Technologies LLC (MMT) from Arcline Investment Management for approximately $685 million in cash (including certain tax benefits). The transaction, previously announced on December 10, 2025, was financed with cash on hand and proceeds from Perimeter’s senior secured notes offering that closed on January 2, 2026. MMT provides highly engineered machinery and related aftermarket consumables, parts, and services used in manufacturing minimally invasive medical devices.

BioStem Technologies acquired BioTissue Holdings' non-ocular surgical and wound care business via an asset purchase, including the Neox and Clarix product lines and associated commercial infrastructure (national salesforce, agents, and GPO contracts). The deal includes approximately $15 million in upfront cash plus potential additional regulatory and royalty milestone payments, and BioTissue will continue manufacturing the products for BioStem under the new arrangement.

Strive, Inc. (Nasdaq: ASST) announced it has completed its previously announced acquisition of Semler Scientific (Nasdaq: SMLR). Following the closing, Semler Scientific operates as a Strive subsidiary, and Strive indicated plans to expand the subsidiary’s early disease detection product mandate while also highlighting its bitcoin treasury position.

Emergency Care Holdings (ECH), backed by Bridgefield Capital, completed the acquisition of Koninklijke Philips N.V.’s Philips Emergency Care business. The carved-out business will operate as Heartstream and continue marketing select products under a Philips brand license, forming the foundation of ECH’s global emergency medical technology platform focused on the pre-hospital care market.

An investment subsidiary of Investindustrial Growth III SCSp acquired Proveris Scientific Corporation, a Hudson, Massachusetts-based manufacturer of spray and aerosol analytical testing instrumentation, related software, and laboratory solutions for the pharmaceutical industry (especially orally inhaled and nasal drug products). Founder and CEO Dino J. Farina will remain with the business and reinvested as a minority shareholder alongside Investindustrial, which plans to use Proveris as a foundation to build a broader pharmaceutical testing equipment group through organic growth and acquisitions.

Ingersoll Rand acquired Scinomix, a United States-based provider of laboratory automation technologies, to expand its life sciences automation capabilities. The deal will strengthen Ingersoll Rand’s Life Sciences platform within its Precision and Science Technologies segment, with Scinomix integrated into that platform.

DirectMed Imaging, a portfolio company of Frazier Healthcare Partners, acquired Tri-Imaging Solutions and will combine the businesses into a single integrated aftermarket diagnostic imaging parts, systems, service, and technical training provider. The combined organization will operate under the Tri-Imaging name and be led by the existing Tri-Imaging leadership team with Eric Wright as CEO.

Solventum completed its acquisition of Acera Surgical, a privately held bioscience company focused on fully engineered materials for regenerative wound care. The deal expands Solventum’s MedSurg/advanced wound care portfolio into synthetic tissue matrix technology for acute care settings in the United States.

KVP International acquired SafePath Laboratories and IVD Research (together known as SafePath-IVD), a Carlsbad, California-based diagnostics manufacturer and contract development and manufacturing organization (CDMO) with FDA, ISO 13485, and USDA licenses. The deal strengthens KVP’s veterinary diagnostics offering and expands capabilities in point-of-care/rapid tests while enabling SafePath-IVD to continue growing its human diagnostics and CDMO businesses; financial terms were not disclosed.

Surmodics completed a merger with Biocoat, alongside a related divestiture of certain Biocoat assets. The portion of Biocoat’s legacy operations that was not divested now operates within Surmodics as a newly named division, Surmodics Services & Technologies, headquartered in Horsham, Pennsylvania.

Aptyx, a life sciences device and components designer and manufacturer backed by TruArc Partners, acquired Argos Corporation, a Massachusetts-based precision medical extrusion company. The deal expands Aptyx’s precision extrusion capabilities and capacity, establishing a Boston-area Precision Extrusion Center of Excellence to support interventional and catheter-based device markets.

CQ Medical acquired Bionix’s Radiation Therapy business unit, expanding CQ Medical’s radiotherapy patient positioning and marking product portfolio. Following the transaction, Bionix will continue operating its Ambulatory Care business unit independently from its headquarters in Maumee, Ohio, while CQ Medical plans to transition the acquired radiation therapy product lines and operations into its existing manufacturing locations.

Abyrx, Inc. and Kairuku, Inc. announced the closing of a combined $450 million transaction consisting of a management-led buyout and new capital, creating newly formed holding company MedEdge Holdings LLC. MedEdge will own and integrate Abyrx’s commercial-stage biosurgical product portfolio with Kairuku’s SaaS platform for point-of-care commercial operations, and plans to use the capital to acquire and in-license additional commercial-stage surgical product companies.

Vance Street Capital acquired Injectech, a precision fluid management components manufacturer headquartered in Fort Collins, Colorado, from The West Group (TWG). The deal adds Injectech to Vance Street’s VSC Medical Molding platform (alongside Plastic Design Company and Resenex) to expand single-use fluid management solutions for medical device, life science, and bioprocessing markets.

Prescott's Med acquired Tenacore, a Costa Mesa, California-based provider of depot-based medical device repair, parts, and technical support. The deal expands Prescott's Med's nationwide depot network, inventory, and repair capabilities across a broad range of biomedical equipment for hospitals and other healthcare customers.

Evident has completed its acquisition of Pramana, Inc., which develops autonomous whole slide imaging systems for digital pathology. The deal is intended to strengthen Evident’s position in digital pathology by combining Evident’s optical imaging platform with Pramana’s AI-enabled imaging automation and workflow systems for hospitals, research settings, and academic labs.

JLL Partners acquired Parks Medical Electronics, a manufacturer of Doppler ultrasound and non-invasive vascular testing systems, and merged it with Vascular Technology Incorporated (VTI). The combination is intended to build a medical device platform focused on vascular diagnostics and robotics applications, offering a broader portfolio of single-use and reusable Doppler systems for hospital, clinic, operating room, and veterinary settings.

SK Capital Partners has completed its acquisition of LISI Group’s Medical division and rebranded the business as Precera Medical, an independent medical device CDMO. As part of the transaction, LISI Group retained a minority stake, and the company relocated its headquarters to Big Lake, Minnesota (while operating four manufacturing sites across Minnesota and France). The transaction closed on October 31, 2025, with Dylan Hushka appointed CEO.

ARCHIMED Diagnostics (the diagnostics team of healthcare private equity firm ARCHIMED) closed the carve-out acquisition of Fremont, California-based ARK Diagnostics from South Korea’s Soulbrain Holdings in a transaction valuing ARK at an enterprise value of $428 million. ARCHIMED acquired 60% of ARK via its MED Platform II fund, while Soulbrain reinvested and retained a 40% stake; the parties also signed a joint venture agreement to accelerate ARK’s technology, product development, and global expansion.

Allegheny Performance Plastics announced the acquisition of Holbrook Tool and Molding, Inc., a precision injection molding and tooling company based in Meadville, Pennsylvania. The deal expands Allegheny’s medical manufacturing capabilities, adding expertise in tight-tolerance mold building, precision tooling, insert molding, and complex component manufacturing.

Precision BioLogic Inc. announced the strategic acquisition of George King Bio-Medical, Inc., expanding its hemostasis/coagulation diagnostic products portfolio. George King Bio-Medical will continue regular operations while the combined organization develops longer-term plans under the Precision BioLogic umbrella.

Vance Street Capital, a Los Angeles-based private equity firm, partnered with (acquired a stake in) Molded Rubber and Plastic Corporation (MRPC), a family-owned, ISO 13485-certified medical device contract manufacturer. Headquartered in Butler, Wisconsin, MRPC provides end-to-end medical device lifecycle support including silicone and thermoplastic molding, cleanroom assembly, packaging, and sterilization management. Transaction terms were not disclosed, and MRPC’s CEO Greg Riemer will continue to lead the business.

Zimmer Biomet Holdings, Inc. has completed the acquisition of Monogram Technologies Inc., an AI-driven orthopedic robotics company. The deal expands Zimmer Biomet’s orthopedic robotics and navigation portfolio by adding Monogram’s surgeon-guided semi- and fully autonomous robotic technologies and provides contingent value rights tied to future milestones.

GSI Group Holdings (a portfolio company of L Squared Capital Partners) acquired GenesisBPS, a designer and manufacturer of specialized benchtop blood, plasma and cell-therapy processing equipment and related laboratory consumables. The acquisition adds mission-critical blood processing instruments and consumables to GSI Group’s global platform of laboratory benchtop equipment and single-use product brands serving life sciences, R&D, industrial and academic markets.

Ahlstrom acquired EBF, a Greenville, South Carolina-based manufacturer of natural fiber-based medical devices used for the collection and preservation of biological samples, including newborn screening 903 diagnostic cards and procedure packs. EBF will join Ahlstrom’s Filtration and Life Sciences business, expanding Ahlstrom’s converting capabilities (e.g., advanced printing, sequential numbering, and custom packaging) and strengthening its position in diagnostic testing materials for lab and life sciences applications.

Precision Cell Systems (PCS) acquired BennuBio to expand into the 3D cell culture and multicellular model analysis market. The deal adds BennuBio’s Velocyt imaging flow cytometer to PCS’s portfolio for single-cell analysis, cell therapy, drug discovery, and bioprocessing workflows. BennuBio’s lead investor Tramway Ventures will join the PCS syndicate following the acquisition.

Artemis Capital Partners, a Boston-based private equity firm, announced the acquisition of Millrock Technology Inc., a designer and manufacturer of freeze-drying (lyophilization) instrumentation and process development solutions for pharmaceutical, biotech, and diagnostics customers. Millrock will continue to operate independently from its facility in Kingston, New York, as Artemis invests to support the company’s growth and innovation.

Sheridan Capital Partners completed an investment in Currier Plastics, a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences. Concurrent with the close, Currier appointed healthcare manufacturing veteran Andrew McLean as its new CEO. Financial terms were not disclosed.

Resonetics acquired Eden Holdings, which includes Eden Manufacturing and Eden Tool, to expand its precision manufacturing capabilities for critical medical devices. The deal adds injection molding capabilities (precision micro-molding and insert molding) along with advanced machining and tooling, complementing Resonetics’ established metal processing and expanding Swiss machining and EDM offerings.

Keensight Capital acquired a majority stake in Isto Biologics, a regenerative MedTech company developing and manufacturing orthobiologic bone graft solutions. The stake was purchased from Thompson Street Capital Partners, which will retain a minority ownership position alongside Isto Biologics’ management team.

Biogen agreed to acquire Alcyone Therapeutics to expand its drug delivery solutions portfolio, centered on advancing Alcyone’s ThecaFlex DRx system for intrathecal delivery of antisense oligonucleotides. Under the deal, Biogen will take over end-to-end development, commercialization, and manufacturing, and Alcyone employees will join Biogen’s product delivery solutions team. Alcyone will receive $85 million upfront plus potential milestone payments, while Alcyone’s remaining therapeutic assets will be divested into Neela Therapeutics.

SAM Medical, a provider of pre-hospital emergency medical products and a wholly owned subsidiary of Tri-Tech Forensics, Inc., announced it has acquired TyTek Medical, part of TyTek Group. The deal expands SAM Medical’s proprietary emergency medical product portfolio, adding TyTek Medical’s chest decompression needle line, and TyTek Medical’s operations will be moved to Tualatin, Oregon.

Aspen Surgical, a portfolio company of Audax Private Equity, announced it has acquired Cygnus Medical and Flagship Surgical to expand its perioperative medical device portfolio. The Cygnus Medical acquisition adds infection control and instrument/scope-care solutions and supports Aspen’s entry into the endoscopy market, while Flagship Surgical adds OR safety and fluid management solutions. Financial terms were not disclosed.

TEAM Technologies ("TEAM Tech"), a portfolio company of Arlington Capital Partners, acquired TAG3 Engineering LLC, a MedTech design, development, and manufacturing firm based in Sunrise, Florida. The deal expands TEAM Tech’s front-end medical device design and innovation capabilities and strengthens its end-to-end offering from concept and development through commercial-scale manufacturing, particularly in minimally invasive and interventional device markets.

Avanos Medical, Inc. acquired Nexus Medical, LLC, a privately held medical device company headquartered in Lenexa, Kansas. The deal adds Nexus’ proprietary TKO anti-reflux needleless connector technology to Avanos’ Specialty Nutrition Systems business to strengthen nutrition and medication delivery in high-acuity critical care settings such as NICUs and PICUs. Avanos financed the acquisition using available cash and expects it to be immediately accretive to revenue growth and earnings per share.

B. Braun SE, through its surgical division Aesculap, acquired True Digital Surgery (TDS), a Goleta, California-based developer of robotic-assisted 3D digital surgical microscopy/exoscope technology. B. Braun previously held a minority stake in TDS and will now bring TDS’s team, intellectual property, and R&D capabilities in-house to accelerate development of the AEOS digital exoscope platform for neurosurgery, spine, and ENT procedures. Financial terms were not disclosed, and TDS will continue operating as a technology hub in Goleta.

MegaGen Implant acquired BIOLASE, a global manufacturer and innovator in dental laser technology, marking a new ownership chapter for the company. Following the transaction, MegaGen founder Dr. Kwang Bum Park becomes CEO of BIOLASE, with plans to enhance service, investment, training, and innovation across BIOLASE’s dental laser platforms.

Safe Life, a global provider of life-saving equipment and training, acquired AED Brands, a Georgia-based distributor of automated external defibrillators (AEDs), related consumables, and readiness services. The deal expands Safe Life’s North American footprint and strengthens its position in the AED and life-saving readiness market.

Thermo Fisher Scientific completed the acquisition of Solventum’s Purification & Filtration (P&F) business for approximately $4.0 billion in cash (before customary adjustments). The acquired unit—now Thermo Fisher’s Filtration and Separation business within its Life Sciences Solutions segment—adds bioprocessing, healthcare/industrial filtration and membrane technologies; the drinking water filtration business was excluded from the transaction.

PainTEQ, a Tampa, Florida-based developer of minimally invasive solutions for sacroiliac (SI) joint dysfunction, completed a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners. The transaction also included a new equity investment from MVolution Partners to fund clinical studies, next-generation product development, and expansion of PainTEQ’s U.S. commercial presence. Financial terms were not disclosed.

Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management, acquired Innova Design, Inc., a pioneer in catheter laser bonding equipment. The deal expands MMT’s bonding technology suite for medical device and industrial manufacturers, adding Innova’s laser bonder platform to complement MMT’s existing hot box and split die bonding solutions.

Partners Group, acting on behalf of its clients, agreed to acquire a significant minority stake in restor3d in the company’s first institutional investment. The transaction includes $65 million of new equity from Partners Group as part of a $104 million total raise (including $39 million from existing shareholders) to support restor3d’s product innovation and commercial expansion in personalized orthopedic implants.

HistoSonics, a University of Michigan spin-out and developer of the Edison Histotripsy System, sold a majority stake to a syndicate of global investors led by K5 Global, with participation from Bezos Expeditions and Wellington Management, valuing the company at $2.25 billion. The investment is intended to accelerate HistoSonics’ expansion beyond liver tumors into additional indications including kidney, pancreas, and prostate treatments.

HKW, a middle-market private equity firm, partnered with the Cherubini family to recapitalize AliMed Inc., a national provider of branded medical products. AliMed, headquartered in Dedham, Massachusetts, manufactures and distributes acute and non-acute medical products and devices. Financial terms were not disclosed.

Demetra S.p.A. announced the full acquisition of OrthoFundamentals, LLC, a U.S.-based developer of implants and sterile-packed, single-use instrument kits for sacroiliac (SI) joint fusion procedures. The deal supports the launch of Demetra Spine, a new global spine division focused on value-based, minimally invasive and infection-risk-reducing spine surgery solutions.

UFP Technologies, Inc. (Nasdaq: UFPT) announced the acquisitions of Universal Plastics & Engineering Company, Inc. (UNIPEC) and Techno Plastics Industries, Inc. (TPI) to expand its tight-tolerance film components and thermoplastic molding capabilities for the medical device market. UNIPEC, headquartered in Rockville, Maryland, manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in Class III implantable medical devices, and was advised by Trout Capital Advisors on its sale. The transactions were financed with available cash and borrowings under UFP’s existing credit facility.

Straits Orthopaedics (Mfg) Sdn Bhd acquired Medin Technologies, Inc., a U.S.-based manufacturer of sterilization cases and trays for the orthopaedic sector. The deal expands Straits’ product offerings and global manufacturing footprint, with Medin operating facilities in Totowa, New Jersey and Manchester, New Hampshire. Quadria Capital, an investor in Straits Orthopaedics, supported the transaction; Kirkland & Ellis and PwC advised Quadria and Straits.

EQT Life Sciences, through its LSP 7 fund and EQT Health Economics strategy, co-led an oversubscribed $56 million Series D financing in Neuros Medical, Inc. The proceeds will support U.S. commercialization of Altius, the company’s FDA-approved direct electrical nerve stimulation system for chronic, intractable post-amputation pain in adult amputees.

Quanterix Corporation completed its previously announced acquisition of Akoya Biosciences, Inc., creating an integrated platform for measuring biomarkers across blood and tissue. Under the amended merger agreement, Quanterix paid approximately $20 million in cash and issued about 7.8 million shares of common stock to Akoya shareholders and equity awardholders, and also repaid Akoya’s debt at closing.

Innovia Medical, a portfolio company of Inverness Graham Investments, completed the acquisitions of Grace Medical and Hurricane Medical. The deals expand Innovia’s single-use surgical products platform—adding ENT implants/instruments through Grace Medical and ophthalmic surgical products through Hurricane Medical—to build a more vertically integrated specialty surgical manufacturer. Barings provided senior secured credit facilities to finance the acquisitions; transaction terms were not disclosed.

TEAM Technologies (TEAM Tech) acquired Duke Empirical, Inc., expanding TEAM Tech’s medical device manufacturing and design capabilities in minimally invasive, cardiology, and interventional markets. Duke Empirical, headquartered in Morgan Hill, California, designs and manufactures advanced catheters and minimally invasive delivery systems, adding front-end design, medical extrusion, and high-precision assembly capabilities to TEAM Tech’s global manufacturing footprint.

TEAM Technologies, a portfolio company of Arlington Capital Partners, acquired Duke Empirical, Inc. Duke Empirical, headquartered in Morgan Hill, California, designs, develops, and manufactures advanced medical devices—particularly catheters and minimally invasive delivery systems for interventional cardiovascular applications—expanding TEAM’s outsourced medical device manufacturing capabilities and capacity.

JLL Partners announced an investment in Vascular Technology, Incorporated (VTI), a medical device company focused on innovative surgical devices and single-use operating room consumables. JLL partnered with entrepreneur Nilendu Srivastava and the VTI management team to accelerate growth and expand VTI’s product portfolio. As part of the transaction, Greg Groenke was appointed CEO and Lars Marcher was named Executive Chairman.

HealthpointCapital acquired a majority stake in ImmersiveTouch, Inc., an extended reality surgical platform company. ImmersiveTouch’s FDA 510(k)-cleared ImmersiveView software uses virtual reality and augmented reality to support surgical planning, navigation, and patient-customized surgical guides, with a current focus on facial and thoracic trauma procedures. Financial terms were not disclosed.

Verge Medical, a privately held medical technology company based in Campbell, California, acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The deal adds an FDA-cleared peripheral embolic protection solution to Verge Medical’s portfolio for coronary and peripheral vascular interventions.

CenterGate Capital, through an affiliate, has acquired/partnered with The Marena Group, a global provider and manufacturer of medical-grade compression garments, shapewear, and activewear. The Marena Group was sold by The Riverside Company and is headquartered in Lawrenceville, Georgia; CEO Dale Clendon will continue to lead the business as CenterGate supports its next phase of growth.

Bioness Medical, Inc. acquired the assets and business of Harmonic Bionics, Inc., an Austin, Texas-based robotics company developing a bilateral upper-extremity robotic exoskeleton for neurorehabilitation. The acquisition expands Bioness Medical’s neuro rehab portfolio and pipeline, with commercialization expected following regulatory (FDA) clearance. This is Bioness Medical’s first acquisition since becoming independent after being acquired by Accelmed Partners on December 31, 2024.

Averra Holdings, a portfolio company of Banner Capital, announced a partnership with ZIEN Medical Technologies, a Salt Lake City-based medical device CDMO providing design, development, manufacturing, packaging, sterilization, and regulatory/quality services. ZIEN will continue operating under CEO Tim Nieman, and its capabilities are expected to expand within Averra to include turnkey packaging design and manufacturing services. Financial terms were not disclosed.

Avista Healthcare Partners acquired EBI, the bone healing division of Highridge Medical, in a corporate carve-out transaction. EBI, headquartered in Parsippany, New Jersey, provides implantable and non-invasive bone growth stimulation solutions for spinal fusion and fracture nonunion healing. Highridge Medical is an H.I.G. Capital portfolio company, and the divestiture allows Highridge to refocus on its core spine solutions business.

Addtronics, LLC acquired DAC International, Inc., a manufacturer of ultra-precision equipment used in contact lens and intraocular lens (IOL) production. Route 2 Capital Partners provided subordinated debt and equity financing to support the transaction, and Addtronics is backed by Kaho Partners. DAC will continue to be led by its president, Ken Payne, following the acquisition.

SCOPE Health Inc. announced the acquisitions of two eye-care technologies: OPTASE MX2, a cloud-based meibographer, and OPTASE Connect, a personalized digital connectivity solution powered by Medbot technology. The additions expand SCOPE Health’s tools for imaging, patient engagement, and digital connectivity for eye care practices across its served markets.

Accelus, a privately held medical technology company focused on expandable spinal implant technologies, closed a new equity financing round led by Concord Health Partners. The funding will support Accelus’s continued commercial expansion and further development of its spinal implant product pipeline.

Merit Medical Systems acquired Biolife Delaware in a merger, making Biolife a wholly owned subsidiary of Merit. The cash transaction, including assumption of liabilities, was valued at approximately $120 million and adds Biolife’s StatSeal and WoundSeal hemostatic device portfolio to Merit’s hemostasis offerings.

Brookfield Asset Management’s private equity business, together with its affiliate Brookfield Business Partners and CDPQ, completed the acquisition of Antylia Scientific from GTCR for approximately $1.3–$1.34 billion. Antylia Scientific, headquartered in Vernon Hills, Illinois, manufactures and distributes consumables and testing equipment serving biopharmaceutical, clinical diagnostics, environmental, and life sciences laboratories.

Waters Corporation acquired Halo Labs, a venture-backed scientific instrumentation and consumables company specializing in imaging technologies for aggregate and subvisible particle analysis in biopharmaceutical products. The acquisition adds Halo Labs’ Aura platform to complement Waters’ Wyatt Technology light scattering solutions, strengthening Waters’ biological/bioprocessing testing capabilities for large molecule therapies including cell, protein, and gene therapies.

Huma Therapeutics announced it has acquired Aluna (also known as Knox Medical Diagnostics, Inc.), a U.S.-based company focused on intelligent remote monitoring and management of respiratory diseases. Separately, Huma also announced a partnership and investment relationship with Eckuity Capital to support Huma’s expansion and ongoing M&A strategy, including integrating Aluna’s respiratory monitoring solutions into the Huma Cloud Platform.

SSI Diagnostica Group, a Denmark-headquartered infectious disease in-vitro diagnostics developer and manufacturer, is acquiring Gulf Coast Scientific (GCS), a Florida-based company focused on Urea Breath Testing for Helicobacter pylori. The deal expands SSI Diagnostica Group’s gastrointestinal disease testing portfolio and strengthens its footprint in the US clinical diagnostics market.

CardioOne, a growth and operational partner for independent cardiology practices, announced it has acquired CardioDiagnostics, an advanced cardiac monitoring platform. The deal adds CardioDiagnostics’ ECG and remote patient monitoring (RPM) capabilities—supported by advanced analytics—into CardioOne’s practice management technology and services platform to expand virtual cardiology care offerings.

Lexington Medical, a Bedford, Massachusetts-based manufacturer of minimally invasive endoscopic surgical stapling devices, secured a strategic growth investment from Ampersand Capital Partners. The investment is intended to accelerate Lexington’s product innovation, smart manufacturing initiatives, and global expansion as demand for its AEON stapling platforms grows.

Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management, acquired Mayer Engineering, maker of the FEPeeler catheter manufacturing tooling products. The acquisition expands MMT’s heat shrink removal tooling and braided catheter cutting capabilities, strengthening its medical device manufacturing solutions offering.

Align Capital Partners-backed Premier Biotech completed two acquisitions: OraSure Technologies’ substance abuse testing business line (the OraSure Toxicology Line) and the Mexican subsidiary of Green Earth Biomedical LLC. The deals expand Premier’s oral-fluid toxicology testing offerings and strengthen its distribution footprint in Mexico and Latin America to support broader international growth.

KRTL Holding Group Inc. announced it has acquired 100% of Neurogen Brain Balancing, LLC, a California-based neurotechnology company focused on brain balancing therapies and personalized cognitive optimization. The stock-based transaction makes Neurogen a subsidiary of KRTL and includes a collaborative profit-sharing agreement, along with KRTL support for market expansion and FDA-related regulatory services.

Tyber Medical, LLC was acquired by Montagu Private Equity in a transaction that closed on 8 April 2025. As part of the deal, Tyber Medical combined with Montagu’s existing portfolio companies Resolve Surgical Technologies and Intech to form a next-generation solutions provider to the medical device industry.

Surplus Solutions LLC, a portfolio company of NMS Capital, acquired Certified Genetool, a San Francisco-based provider of certified and refurbished laboratory instruments and related technical services. The deal expands Surplus Solutions’ refurbished lab equipment capabilities and service offering, particularly in areas such as flow cytometry, to support customers across the biotechnology, pharmaceutical, and life sciences sectors. Transaction terms were not disclosed.

Viscogliosi Brothers, LLC completed its previously announced acquisition of Stryker’s U.S. spine business, which will operate as a standalone company named VB Spine, LLC. Barings, LLC and Texas Capital Bank supported the transaction as financial partners, and Viscogliosi Brothers (including Viscogliosi Brothers Watermark Holdings, LLC) are equity investors in VB Spine. VB Spine is also pursuing the acquisition of Stryker’s international spine businesses, subject to legal and regulatory requirements.

Eargo and hearX (maker of the Lexie hearing aid brand) completed their merger, creating a combined company named LXE Hearing. Patient Square Capital backed the transaction with an additional $100 million investment to support the new hearing health company focused on the over-the-counter hearing aid market.

Ubiqconn Technology announced the acquisition of E3 Displays to expand its North American presence and enhance its display solutions portfolio. E3 Displays will continue operating independently under its existing brand while leveraging Ubiqconn’s global resources, with the combined capabilities focused on advanced optical bonding and rugged, high-performance displays for mission-critical markets.

Advanced Instruments, a wholly owned subsidiary of Patricia Industries (Investor AB), acquired Nova Biomedical from its founding shareholders for an enterprise value of USD 2.2 billion. The businesses are being combined into a diversified global life science tools platform that will operate under the Nova Biomedical name and be led by Advanced Instruments CEO Byron Selman, with Nova’s founders remaining as consultants.

Plastiflex Group N.V., backed by IK Partners, announced the acquisitions of Smooth-Bor Plastics and TIK d.o.o. to strengthen its healthcare tubing and medical device manufacturing capabilities. Smooth-Bor adds heated tubing systems for CPAP and respiratory care (headquartered in Laguna Hills, California), while TIK adds disposable medical devices including coated urethral catheters and follicle aspiration needles (headquartered in Kobarid, Slovenia).

ENDYMED Ltd completed a full merger with its majority shareholder, Shanghai Haohai Biological Technology Co., Ltd. The consolidation is intended to strengthen ENDYMED’s position in China and improve global operational efficiency, supply chain streamlining, and innovation across energy-based aesthetic treatment systems.

Amphenol Corporation acquired LifeSync Corporation, a developer and manufacturer of disposable and reusable patient monitoring devices and connections used in hospitals and other high-acuity settings. Capitala Group, which had invested in LifeSync alongside HealthEdge Investment Partners, fully exited its equity position as part of the transaction.

Grovecourt Capital Partners acquired IMRIS Imaging, Inc., a provider of intraoperative MRI suites and advanced neurosurgery operating theatres. IMRIS, founded in 2005 and headquartered in Chaska, Minnesota, designs, manufactures, and services movable intraoperative MRI systems used by hospitals and cancer centers worldwide; financial terms were not disclosed.

NanoVibronix, Inc. completed its acquisition of privately held ENvue Medical Holdings Corp., an enteral feeding solutions company, in a stock-for-stock transaction. Following the closing, ENvue will become a wholly owned subsidiary of NanoVibronix, creating a combined platform in enteral feeding technology and therapeutic medical devices.

Nanovis sold certain nano surface technology assets and related IP rights to Medtronic for use in developing Medtronic’s next-generation PEEK interbody fusion devices. The acquired rights relate to Sites Medical’s OsteoSync titanium pads. Financial terms were not disclosed.

PROTEOR acquired Filament Innovations, a specialist in 3D printing solutions for the orthotics and prosthetics (O&P) industry. The deal expands PROTEOR’s digital solutions portfolio—adding 3D printing capabilities alongside scanning and rectification software—and is intended to accelerate development of customized O&P medical devices and streamline digital workflows.

Riveria Investment Group ("Riveria") announced an investment in On The Right Track Systems ("OTRT"). Headquartered in Tribeca, New York, OTRT provides proprietary hospital privacy curtains and track systems, along with cloud-based changeout/compliance software, for the healthcare market.

Arterex, a global medical device developer and contract manufacturer, acquired Adroit USA Inc., a vertically integrated contract manufacturer focused on complete medical device manufacturing. Adroit USA, founded in 2003 and headquartered in Pleasanton, California, adds ISO 13485-certified manufacturing capacity in Bangalore, India and an engineering applications development lab in Milpitas, California, expanding Arterex’s metal fabrication, machining, and medical manufacturing capabilities.

Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management, acquired GenX Medical, a U.S.-based supplier of medical tubing and custom extrusions. The deal expands MMT’s specialty manufacturing services and strengthens its extrusion capabilities for medical device manufacturers; GenX Medical founder Tyler Ware will join MMT as Technical Director.

Aspen Medical Products, LLC, a spine orthopedics and pain therapy solutions provider, has acquired Advanced Orthopaedics, a manufacturer and supplier of orthopedic bracing solutions and soft goods. The deal expands Aspen’s portfolio beyond spine and strengthens its position and global reach in the growing bracing and supports market.

On January 24, 2025, DirectMed Imaging acquired a substantial portion of Richardson Electronics’ Richardson Healthcare business (including the Fort Mill, South Carolina operation) in a strategic asset sale that closed the same day. As part of the transaction, Richardson Electronics and DirectMed also entered into an exclusive 10-year global supply/distribution arrangement covering repaired Siemens CT X-ray tubes, and Richardson will continue manufacturing ALTA CT X-ray tubes for DirectMed for approximately 12–18 months while remaining Richardson Healthcare assets are consolidated into Richardson’s PMT business unit.

Astorg has signed a definitive agreement to acquire FUJIFILM Irvine Scientific’s Medical Media Business (Irvine Scientific MBU) from FUJIFILM Irvine Scientific. The business supplies culture and vitrification media used in IVF, infertility research, and cytogenetic analysis, and will be combined with Astorg’s recently acquired Hamilton Thorne and Cook Medical’s Reproductive Health business to create a global ART MedTech leader. Financial terms were not disclosed.